Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae

NCT05293873 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Sequelae of Injuries of Head

Interventions

BIOLOGICAL: autologous bone marrow-derived mononuclear cell transplantation
OTHER: Rehabilitation therapy

Sponsor

Vinmec Research Institute of Stem Cell and Gene Technology